Objectives: Residents living in a long-term care facility (LTCF) are more susceptible to infections. Treatment with antimicrobials is sometimes necessary; however, antibiotic use is considered one of the most important drivers of the development of antibiotic resistance. Surveillance data on antibiotic use in these LTCFs are necessary to get more insight into these patterns. The objective of this study was to describe antibiotic use in LTCFs in the Netherlands.
Introduction
Residents living in a long-term care facility (LTCF), especially the elderly, are more susceptible to infections because of several factors related to ageing. 1 Infections are easily spread in such a closed community, where sick and vulnerable people live close together. Diagnosing an infectious disease in elderly people can be very challenging, as they may present with atypical symptoms and other chronic diseases that should be taken into account. Microbiological analysis of samples from residents in case of a suspected infection can assist in diagnosis, but this is not common practice in LTCFs. 2 Antimicrobials may be needed, but the combination of an increased risk of infection and problems with diagnosing an infection in elderly people hampers appropriate prescribing of antimicrobials in LTCFs. Since antibiotic use is considered one of the most important drivers of the development of antibiotic resistance, rational use of antimicrobials is essential. 3 To get more insight into these patterns of developing resistance and antibiotic use, the availability of surveillance data is necessary. Limited data are available, however, for LTCFs. On a European level, two large-scale point prevalence studies on antibiotic use in LTCFs are known. One was performed in 2009 under the auspices of the European Surveillance of Antimicrobial Consumption (ESAC) network, including a total of 85 LTCFs in 15 European countries. 4 The other was set up by the ECDC (European Center for Disease Control and Prevention) to determine the prevalence, antibiotic use and determinants associated with healthcare-associated infections (HAIs) in LTCFs (HALT1 and 2). In the Netherlands, 10 LTCFs participated in this study in 2010 5 and 4 in 2013, 6 and showed low use of antimicrobials compared with other European countries.
At a national level, the Centre for Infectious Disease Control (CIb) of the National Institute for Public Health and Environment (RIVM), started a nationwide network in 2009 to monitor the prevalence of some infectious diseases in LTCFs. 7 One of the aims of this network is to provide surveillance data for local interventions and national policymaking. Nineteen to 25 nursing homes participate in this study every year. 8 Since 2011, the Dutch Working Party on Antibiotic Policy (SWAB) has also provided data on antibiotic use in Dutch LTCFs in NethMap. The pattern of antibiotic use and prevalence of resistance in LTCFs has only been investigated on a small scale up to now. Van der Donk et al., 10, 11 for instance, investigated antibiotic use and the occurrence of resistance in Staphylococcus aureus and Escherichia coli in 16 and 5 LTCFs, respectively. To get more insight, a project was set up in the Netherlands to investigate the resistance profile of commensal flora in Dutch LTCF residents in relation to use of antimicrobials at the LTCF level. 12 In this article, data on antibiotic use in the participating Dutch LTCFs are reported.
Methods

Data collection
For a study on the carriage of antimicrobial-resistant commensal bacteria by Verhoef et al., 12 177 Dutch LTCFs with .50 beds per location at the start of the study in 2012 were asked to participate. 13 From the same cohort of LTCFs, data about antibiotic usage were collected retrospectively at an institutional level. A letter was sent to the pharmacy of each LTCF participating between 2012 and 2014. Information about antibacterials for systemic use [ATC (Anatomical Therapeutic Chemical) code J01] at the ATC5 level (according to the WHO classification) 14 for each individual location was collected for the year preceding the date of microbiological sampling. In the ATC classification system, active substances are divided into groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. 15 The ATC/DDD classification from the WHO version 2014 was used to calculate the DDDs for the different antimicrobials using the ABC calculator. 16 For each LTCF, the number of DDDs per 1000 residents per day was calculated, assuming 100% bed capacity utilization. If data were only available for a cluster of LTCFs, the calculation of DDDs/1000 residents/day was based on the cumulative number of beds and the total number of DDDs of antimicrobials used for the cluster of LTCF locations together. The same number of DDDs/1000 residents/day was attributed to each location.
Data analysis
Quantitative use of antimicrobials was analysed for each LTCF individually and a weighted mean for all the LTCFs included was calculated. Use was expressed as absolute consumption (DDD/1000 residents/day). Relative consumption was calculated as a percentage at the ATC4 level as a proportion of the total use of J01 (ATC2 level). The top 10 of the most used antibiotics at ATC5 level was also calculated. All systemic antimicrobials used were ranked from high to low and subsequently cumulative percentages were calculated.
LTCF characteristics
A questionnaire was sent to all LTCFs between 2012 and 2014, in which general characteristics about their location were collected, such as the numbers of beds and personnel and the presence of an antimicrobial or drug formulary committee. The level of care for each resident was also reported. This is a measure set up by the Dutch Centre for Assessment of Care (CIZ), which represents the amount and intensity of care and support needed by a resident (in a range from 1 to 10).
An independent sample t-test was performed with SPSS version 20, to indicate a relationship between the total use of antimicrobials (J01) and dichotomous variables. A bivariate Pearson correlation analysis was performed to identify factors associated with the total use of antimicrobials (J01) and other, non-dichotomous variables. Differences between LTCFs that completed the questionnaire and LCTFs that did not complete the questionnaire were assessed using an independent sample t-test. Statistical significance was set at P , 0.05.
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Results
Of the 177 LTCFs approached for participation, 96 locations were able to provide data on antibiotic usage. Sixty-eight of the 96 LTCF locations (71%) completed the questionnaire; however, only 31 LTCFs completed the entire questionnaire.
Total use of systemic antimicrobials varied between 2 and 197 DDD/1000 residents/day, with a mean of 73 DDDs/1000 residents per day. The mean distribution of systemic antimicrobials on ATC4 level is shown in Table 1 . The antimicrobial that was used the most was co-amoxiclav (23 DDDs/1000 residents/day, range 0-70), followed by nitrofurantoin derivatives and fluoroquinolones (both 12 DDDs/1000 residents/day, range 0-38 and 0-52, respectively). Relative antibiotic use of these top three antimicrobials covered 64% of the total use of systemic antimicrobials in the participating LTCFs. Table 2 depicts the top 10 antibiotics used at ATC5 level. The total of these 10 antimicrobials account for 92.6% of the total volume. The total number of different antimicrobials used in LTCFs was 42 (data not shown).
Seventy-seven percent of the residents were older than 75 years. Most residents had a ZZP (overall care level needed) of 6, which means that they needed help in a protected environment with intensive guidance and care. LTCFs had a median of 75 beds and 92.5 nursing staff members per location (Table 3) . No significant correlations between antibiotic use and variables included were found.
Among the 68 participating LTCFs that provided questionnaire data, 54 (82%) of the LTCFs that filled in this question had an infection committee, whereas 50 (81%) had an antibiotic/drug committee and 39 (71%) had an antibiotic formulary in place (Table 4) . Statistical analysis revealed no significant correlations between these LTCF characteristics and the amount of antibiotic use (J01) (data not shown). Antibiotic usage data of the LTCFs that completed the questionnaire were compared with antibiotic usage data of LTCFs that did not complete the questionnaire, and no significant differences in antibiotic use were seen. Also, analysis by clusters of LTCFs or analysis after excluding outliers (i.e. a total use of antimicrobials below the national primary care level of 10.45 DDDs/1000 inhabitants per day) did not significantly alter the results in Tables 3 and 4 .
Discussion
This study shows that overall consumption of antimicrobials in Dutch LTCFs is high, although we found a large variation between individual locations. We could not find an explanation, within the examined characteristics, for this variation. Of special concern is the high use of broad-spectrum antimicrobials such as coamoxiclav and fluoroquinolones. It is possible that actual antibiotic use per resident is even higher since the bed capacity in the LTCFs was assumed to be 100% in this study. Participation in the study was voluntary, which might have influenced outcomes. Reasons for no participation were, among others, shortage of personnel and/or involvement in other studies. 12 Results depicted correspond to the data from the national surveillance of antibiotic use in LTCFs, 9 reporting a mean use of 67.02, Antimicrobial use in Dutch long-term care facilities JAC 73.83 and 64.97 DDDs/1000 residents/day for the years 2011, 2012 and 2013, respectively. The most frequently used antimicrobials were also co-amoxiclav followed by nitrofurantoin and fluoroquinolones. In this national surveillance, 55, 28 and 34 different LTCF locations, respectively, participated. Compared with the antibiotic use in acute care hospitals in the Netherlands, relatively more co-amoxiclav was used in LTCFs: 31.6% versus 19.4%. 9, 17 The same holds true for fluoroquinolone use, which is 11.4% in Dutch hospitals and as high as 16.4% in this study. Comparing antibiotic use in LTCFs with that in primary care, tetracyclines and amoxicillin were relatively less used in LTCFs (8.9% and 7.2%, respectively) than in primary care (21.4% and 18.3%, respectively). 9 Only a limited number of different antimicrobials were used in LTCFs, as the top 10 represented 92.6% of the total drug use in LTCFs in the Netherlands. The total number of different antibiotics used was 42; in primary care this number was 50 and in hospital care 64 (SWAB, personal communication). This shows the relatively limited therapeutic options for antibiotic treatment in LTCFs. The limited number of therapeutic options could be explained in part by difficulties in the use of intravenous medication; most of the time oral medication is the only option. This could become a problem once resistance levels rise.
Aside from the results presented in NethMap, 9 there have been no other large surveillance studies describing antibiotic usage in LTCFs in the Netherlands. The HALT study did not publish any results about antibiotic use. 5 The SNIV study, a point prevalence study enquiring into the prevalence of infections, collected data from 66 nursing homes between 2010 and 2014. The most frequently prescribed antibiotic in that study was nitrofurantoin, with 31% of the total number of residents receiving antibiotic treatment, followed by co-amoxiclav and ciprofloxacin. 8 The Roukens et al.
prevalence of residents using antimicrobials on the day of data collection declined from 5.8% in 2011 to 4.1% in 2014. 18 At the European level, McClean et al. 4 found a mean prevalence of antimicrobial prescriptions for residents in LTCFs (percentage of residents that were taking antimicrobials on the day of data collection) of 6.5% in April 2009 and 5% in November 2009. The most commonly prescribed antimicrobials were penicillins (J01C).
Unfortunately, the duration of the antibiotic course was not studied. Rice 19 reported that the simplest approach to using fewer antimicrobials is to reduce the duration of antimicrobial regimens. Therefore, Daneman et al. 20 assessed antibiotic treatment duration among 66 901 residents aged .66 years in 630 LTCFs in Canada in 2010. Of the treatment courses, 44.9% exceeded 7 days in duration. They concluded that antibiotic treatment courses in LTCFs were often prescribed for prolonged treatment durations, and this appears to have been influenced more by prescriber preference than by resident characteristics. Another study on the quality of antimicrobial use in LTCFs in the USA reported that 575 days (42.5%) of antibiotic prescriptions were deemed unnecessary. Of these days of therapy, 334 (58%) were for antimicrobial regimens that were entirely unnecessary. 21 Statistical analysis of several characteristics of LTCFs and antibiotic use did not indicate any significant correlation between the amount of antibiotic use and these characteristics. The variation in care as well as antibiotic use was, however, very large, and of special concern. Key findings of McClean et al. 4 also indicate great variation across and within countries, with no clear explanation for these differences. Daneman et al. 22 investigated antibiotic use and resistance in LTCFs. Although another quantitative measurement was used (antibiotic days per 1000 resident days), they also found a large variation of the total amount of antimicrobials used between the different LTCFs in Canada. The antibiotic agents in this study that were most often prescribed were penicillins, followed by fluoroquinolones. Better insight into factors influencing antibiotic use are urgently needed, both at the resident and institutional level, especially since higher usage was found to be associated with higher resistance levels to these antimicrobials. 12 Antibiotic formularies and treatment guidelines could support prudent use of antimicrobials. Unfortunately, there are only a few guidelines available addressing treatment in LTCFs. 23 On the contrary, concise treatment guidelines are available for primary care 24 as well as acute care hospitals. Only half of the LTCFs that returned the questionnaire have an infection committee or an antibiotic/ drug committee in place, and even fewer had an antibiotic formulary. In the light of lack of treatment guidelines tailored to the setting of LTCFs, such a committee could support proper prescribing of antimicrobials, especially when integrated into a formal antibiotic stewardship programme.
In this study, the reason for prescribing antimicrobials was not evaluated. Given the high level of unexplained variance of use, a study of the appropriateness of prescribing antimicrobials in LTCFs may be worthwhile. Boivin et al. 25 measured the correctness of use in LTCFs and found that 62% of the prescriptions complied with recommendations regarding the choice of drug. Of all the prescriptions, only 17.8% met all stewardship criteria, which implies room for improvement.
Van Buul et al. 3 found that 47%-79% of Dutch long-term facility residents received at least one course of systemic antimicrobials every year and concluded that there is a need for antibiotic stewardship in LTCFs. They started to develop some tailored interventions directed at improving appropriate antibiotic prescribing in long-term care. 26 Since 2014, antibiotic stewardship has been required in Dutch hospitals, and this could also be an option in the Dutch LTCFs.
The limited data presented here illustrate the need for in-depth research into antibiotic use in LTCFs and factors that influence it. More should be done to investigate the pattern and duration of use of antibiotics. Furthermore, the reasons for prescribing antibiotics or the effects of antibiotic prescribing should be investigated when implementing antibiotic stewardship in LTCFs. 
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